Healthy Returns: Drugmakers are capping inhaler prices at $35 in a win for some patients
Publishing timestamp: 2024-03-26 15:35:51
Summary
Three major inhaler makers in the U.S. have agreed to cap the out-of-pocket price of their inhaler products at $35 per month for certain patients. This comes after pressure from the Senate Committee on Health, Education, Labor, and Pensions. The move aims to make inhalers more affordable for patients with chronic lung conditions like asthma and COPD.
Sentiment: MIXED
Keywords: business news, gsk plc, astrazeneca plc, health care industry, united states, biotech and pharmaceuticals,
Source: https://www.cnbc.com/2024/03/26/healthy-returns-drugmakers-are-capping-inhaler-prices-at-35.html